Differential inhibition of thrombin activity and thrombin generation by a synthetic direct thrombin inhibitor (napsagatran, Ro 46-6240) and unfractionated heparin in patients with deep vein thrombosis. ADVENT Investigators.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples